Cannabis Use and Emotional Awareness Difficulties in Adolescents with Co-Occurring Substance Use and Psychiatric Disorders

被引:5
|
作者
Micalizzi, Lauren [1 ,2 ]
Brick, Leslie A. [3 ]
Thomas, Sarah A. [3 ]
Wolff, Jennifer [3 ]
Esposito-Smythers, Christianne [4 ]
Spirito, Anthony [3 ]
机构
[1] Brown Univ, Ctr Alcohol & Addict Studies, Providence, RI 02912 USA
[2] Univ St Joseph, Psychol Dept, 1678 Asylum Ave, Hartford, CT 06117 USA
[3] Brown Univ, Dept Psychiat & Human Behav, Alpert Med Sch, Providence, RI 02912 USA
[4] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA
基金
美国国家卫生研究院;
关键词
Cannabis use; emotional awareness; adolescents; substance use; treatment; co-occurring disorders; MARIJUANA USE; DYSREGULATION; ALCOHOL; TRIAL; PSYCHOPATHOLOGY; ALEXITHYMIA; ASSOCIATION; DEPRESSION; SYMPTOMS; DISTRESS;
D O I
10.1080/10826084.2020.1729202
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Assessing predictors of cannabis use following adolescent substance use treatment may inform essential treatment elements to be emphasized before discharge. Adolescents with low emotional awareness may have limited resources for identifying and overcoming negative emotions, and therefore, use cannabis to regulate emotions. Purpose/objectives: The purpose of this study was to test the hypothesis that emotional awareness difficulties are associated with increased cannabis use across the transition out of substance use treatment. This hypothesis was investigated by applying an autoregressive random-intercept cross-lagged panel-modeling framework to test the fit of alternative models and inform hypotheses about directional associations between cannabis use and emotional awareness difficulties over time. Methods: Participants were 110 adolescents with co-occurring disorders and their families participating in an intensive home-based treatment trial. Adolescents reported on past 7-day cannabis use and difficulties in emotional awareness at baseline and three follow-up assessments across 12 months. Results: At baseline, 54% of the sample reported past-week cannabis use. A directional effect was supported such that difficulties with emotional awareness at 3 months' post-baseline, which corresponded to the approximate end of the treatment program, were associated with increased cannabis use at 6 months' post-baseline, controlling for the stability of cannabis use, and emotional awareness over time. Cannabis use, however, was not associated with subsequent difficulties in emotional awareness (i.e., effects in the opposite direction were not supported). Conclusions/Importance: Emotional awareness difficulties toward the end of a course of intensive outpatient treatment may be associated with increased cannabis use after the completion of treatment.
引用
收藏
页码:1146 / 1154
页数:9
相关论文
共 50 条
  • [21] Access to Treatment for Adolescents With Substance Use and Co-Occurring Disorders: Challenges and Opportunities
    Sterling, Stacy
    Weisner, Constance
    Hinman, Agatha
    Parthasarathy, Sujaya
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2010, 49 (07): : 637 - 646
  • [22] Treatment of Co-occurring Anxiety Disorders and Substance Use Disorders
    McHugh, R. Kathryn
    HARVARD REVIEW OF PSYCHIATRY, 2015, 23 (02) : 99 - 111
  • [23] Managing Co-Occurring Substance Use and Pain Disorders
    Miotto, Karen
    Kaufman, Aaron
    Kong, Alexander
    Jun, Grace
    Schwartz, Jeffrey
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 2012, 35 (02) : 393 - +
  • [24] Treatment of Co-Occurring Psychotic and Substance Use Disorders
    Mueser, Kim T.
    Gingerich, Susan
    SOCIAL WORK IN PUBLIC HEALTH, 2013, 28 (3-4) : 424 - 439
  • [25] Pharmacotherapy for schizophrenia and co-occurring substance use disorders
    Douglas L. Noordsy
    Alan I. Green
    Current Psychiatry Reports, 2003, 5 (5) : 340 - 346
  • [26] Pharmacotherapy for schizophrenia and co-occurring substance use disorders
    Alan I. Green
    Neurotoxicity Research, 2007, 11 : 33 - 39
  • [27] Pharmacotherapy of Co-Occurring Schizophrenia and Substance Use Disorders
    Akerman S.C.
    Brunette M.F.
    Noordsy D.L.
    Green A.I.
    Current Addiction Reports, 2014, 1 (4) : 251 - 260
  • [28] Co-occurring intellectual disability and substance use disorders
    Bhatt, Nita, V
    Gentile, Julie P.
    AIMS PUBLIC HEALTH, 2021, 8 (03): : 479 - 484
  • [29] Pharmacotherapy for schizophrenia and co-occurring substance use disorders
    Green, Alan I.
    NEUROTOXICITY RESEARCH, 2007, 11 (01) : 33 - 39
  • [30] CO-OCCURRING PERSONALITY DISORDERS AND THE USE OF PSYCHIATRIC CARE
    Kasprzak, M.
    Kiejna, A.
    EUROPEAN PSYCHIATRY, 2013, 28